Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis
Lixi Li, Di Zhang, Yun Wu, Jiayu Wang, Fei Ma
Topics & Concepts
TrastuzumabMedicineInternal medicineOncologyBreast cancerDiscontinuationMetastatic breast cancerCancerHER2/EGFR in Cancer ResearchPeptidase Inhibition and AnalysisBreast Lesions and Carcinomas